Pediatrix Medical Group, Inc.

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2026-05-13Shares Purchased (TTM):0Shares Sold (TTM):79,506

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:80,169,330Shares Outstanding:80,881,000Institutional Ownership Pct.:99.12%

Earnings Market Reaction:

Filing Date:2026-08-04Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	289	206	375	340	225	99	230	104	19	8	73	21
Available For Sale Securities Debt Securities Curr…	115	123	124	123	124	120	119	117	114	107	104	104
Accounts Receivable Net Current	228	225	230	231	239	243	260	287	274	284	272	277
Prepaid Expense Current	10	13	13	9	10	12	13	10	12	13	14	11
Income Tax Receivable	11	12	13	4	8	10	13	1	0	5	8	-
Other Assets Current	7	8	9	10	8	8	5	9	10	10	12	8
Assets Current	660	587	764	717	613	492	640	528	429	427	483	421
Property Plant And Equipment Net	39	41	39	39	39	38	39	42	48	74	76	75
Goodwill	1,268	1,268	1,261	1,255	1,243	1,243	1,243	1,239	1,239	1,393	1,384	1,532
Finite Lived Intangible Assets Net	15	16	17	15	9	10	12	13	10	19	21	15
Deferred Income Tax Assets Net	56	66	74	80	89	99	104	119	124	102	103	103
Other Assets Noncurrent	57	55	58	58	71	71	77	79	80	83	82	108
Assets	2,130	2,070	2,247	2,199	2,102	1,993	2,153	2,077	1,995	2,168	2,220	2,326
Liabilities And Stockhold…
Liabilities Current
Accounts Payable And Accrued Liabilities Current	302	237	420	352	303	234	399	-	-	-	351	303
Long Term Debt And Capital Lease Obligations Curre…	186	192	27	25	24	22	21	19	18	16	15	15
Operating Lease Liability Current	12	12	12	12	12	12	13	17	19	21	21	22
Accrued Income Taxes Current	1	1	1	3	2	3	2	3	6	3	2	11
Liabilities Current	502	443	459	393	341	271	434	373	310	247	389	350
Line Of Credit	-	-	-	-	-	-	-	-	-	80	0	0
Long Term Debt And Capital Lease Obligations	398	398	571	577	584	590	597	-	-	-	618	622
Operating Lease Liability Noncurrent	23	27	26	28	30	31	32	40	49	48	47	48
Malpractice Loss Contingency Accrual Undiscounted …	235	237	238	240	244	247	257	255	255	256	251	266
Deferred Income Tax Liabilities Net	59	57	57	38	36	34	34	36	31	34	34	41
Other Liabilities Noncurrent	32	30	30	34	33	31	33	33	32	33	31	31
Liabilities	1,249	1,192	1,381	1,309	1,268	1,204	1,388	1,344	1,289	1,312	1,371	1,358
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	1	1	1	1	1	1	1	1	1	1	1	1
Additional Paid In Capital Common Stock	894	931	948	1,006	1,021	1,016	1,014	1,011	1,006	1,003	1,000	996
Accumulated Other Comprehensive Income Loss Net Of…	-0	0	1	0	0	-0	-1	-0	-2	-2	-2	-4
Retained Earnings Accumulated Deficit	-14	-54	-83	-117	-189	-228	-249	-279	-298	-145	-149	-25
Stockholders Equity	881	879	866	891	834	789	765	732	706	856	849	968
Liabilities And Stockholders Equity	2,130	2,070	2,247	2,199	2,102	1,993	2,153	2,077	1,995	2,168	2,220	2,326
Preferred Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Preferred Stock Shares Authorized	1	1	1	1	1	1	1	1	1	1	1	1
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Common Stock Shares Authorized	200	200	200	200	200	200	200	200	200	200	200	200
Common Stock Shares Issued	81	82	83	86	87	86	86	86	86	84	84	84
Shares Outstanding	81	82	83	86	87	86	86	86	86	84	84	84

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	3.41%	18.48%	26.07%	-	-	-	-	-	-	-	-	-
2025	-2.28%	-3.11%	-13.19%	33.20%	26.16%	36.22%	14.28%	3.75%	2.18%	1.35%	11.14%	21.81%
2024	-19.23%	-16.57%	-8.95%	21.07%	25.53%	38.35%	-1.64%	-7.36%	-9.01%	-20.37%	-22.58%	-15.67%
2023	-	-	-	-	-	-	-10.62%	-3.54%	-5.76%	12.06%	9.22%	-2.84%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	1.32	1.33	1.66	1.83	1.80	1.81	1.47	1.42	1.38	1.72	1.24	1.20
Quick Ratio	1.30	1.30	1.64	1.80	1.77	1.77	1.44	1.39	1.35	1.67	1.21	1.17
Working Capital	158.56M	144.40M	304.60M	324.65M	272.01M	220.62M	205.50M	155.14M	119.06M	179.24M	94.51M	70.08M
Leverage & Debt
Debt to Equity	1.42	1.36	1.59	1.47	1.52	1.53	1.81	1.84	1.82	1.53	1.61	1.40
Interest Coverage TTM	6.31	6.23	5.81	5.40	4.33	-1.34	-1.69	-5.34	-5.15	-0.16	0.17	3.69
Debt Ratio	0.59	0.58	0.61	0.60	0.60	0.60	0.64	0.65	0.65	0.61	0.62	0.58
Efficiency & Turnover
Asset Turnover TTM	0.92	0.95	0.87	0.90	0.95	0.95	0.92	0.91	0.93	0.89	0.87	0.86
Days Sales Outstanding TTM	43.65	44.15	46.69	49.18	48.26	48.60	48.26	51.31	49.67	51.36	52.07	51.86
Receivables Turnover TTM	8.36	8.27	7.82	7.42	7.56	7.51	7.56	7.11	7.35	7.11	7.01	7.04
Per Share Metrics
Diluted EPS TTM	2.15	2.10	1.94	1.89	1.29	-0.96	-1.19	-3.00	-3.02	-0.85	-0.73	1.13
Free Cash Flow Per Share TTM	2.73	2.83	2.95	3.20	2.88	2.54	2.38	1.55	1.41	1.20	1.59	2.00
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	-	-	-	-	-	-	-	-	102.07%	102.12%	102.11%	102.08%
Operating Profit Margin TTM	11.04%	11.30%	10.91%	10.37%	8.51%	-2.66%	-3.41%	-10.94%	-10.64%	-0.34%	0.37%	7.70%
Net Profit Margin TTM	8.96%	9.02%	8.64%	8.44%	5.66%	-4.17%	-4.92%	-12.65%	-12.58%	-3.53%	-3.03%	4.65%
Growth Metrics
Net Revenue Growth (1Y)	0.51%	-2.25%	-4.92%	-4.21%	-3.08%	-1.13%	0.92%	-0.25%	0.36%	0.91%	1.15%	2.83%
Net Income Growth (1Y)	59.03%	-311.52%	-266.94%	-163.89%	-143.64%	16.70%	64.00%	-371.38%	-344.86%	-169.38%	-191.07%	11.08%
EPS Growth (1Y)	69.76%	-320.81%	-265.45%	-163.35%	-142.88%	14.53%	61.78%	-367.02%	-342.11%	-168.57%	-192.47%	10.52%
Valuation Metrics
P/E TTM	11.51	9.93	10.87	8.74	11.07	-14.85	-11.04	-3.83	-2.50	-11.78	-12.66	11.22
P/B TTM	2.28	1.97	2.08	1.59	1.46	1.55	1.43	1.33	0.89	0.97	0.90	1.08
P/S TTM	1.03	0.90	0.94	0.74	0.63	0.62	0.54	0.48	0.31	0.42	0.38	0.52
Market Cap	2.01B	1.73B	1.80B	1.42B	1.22B	1.22B	1.09B	972.30M	629.16M	831.12M	764.47M	1.05B
Enterprise Value	2.31B	2.12B	2.02B	1.68B	1.60B	1.74B	1.48B	887.74M	627.48M	839.53M	1.32B	1.66B
Calculated Values
Free Cash Flow TTM	216.67M	228.51M	247.90M	270.80M	244.55M	214.34M	198.41M	129.65M	117.75M	99.85M	130.66M	165.09M
Net Debt	295.36M	384.99M	222.10M	262.45M	382.82M	513.63M	387.72M	-84.56M	-1.67M	8.41M	560.08M	615.44M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-05-13Sale

Owner: Weis, Shirley A

Title: -

Shares: 36,028

Price/Share: $23.75

Value: $855,665.00

Shares Owned: -

Relationship: Director

Ownership: Indirect

2025-12-15Sale

Owner: Ordan, Mark S

Title: Chief Executive Officer

Shares: 23,000

Price/Share: $22.41

Value: $515,430.00

Shares Owned: 302,805

Relationship: Director,Officer

Ownership: Direct

2025-11-17Sale

Owner: Rucker, Michael A.

Title: -

Shares: 10,478

Price/Share: $23.00

Value: $240,994.00

Shares Owned: 59,101

Relationship: Director

Ownership: Direct

2025-11-06Sale

Owner: Linynsky, Laura A

Title: -

Shares: 10,000

Price/Share: $21.65

Value: $216,500.00

Shares Owned: 32,232

Relationship: Director

Ownership: Direct

2024-11-13Sale

Owner: Ordan, Mark S

Title: -

Shares: 27,600

Price/Share: $15.35

Value: $423,660.00

Shares Owned: 138,683

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-05-13	Weis, Shirley A	Director	-	Indirect	Sale	36,028	23.75	$855,665.00	0	4
2025-12-15	Ordan, Mark S	Director,Officer	Chief Executive Officer	Direct	Sale	23,000	22.41	$515,430.00	302,805	4
2025-11-17	Rucker, Michael A.	Director	-	Direct	Sale	10,478	23.00	$240,994.00	59,101	4
2025-11-06	Linynsky, Laura A	Director	-	Direct	Sale	10,000	21.65	$216,500.00	32,232	4
2024-11-13	Ordan, Mark S	Director	-	Direct	Sale	27,600	15.35	$423,660.00	138,683	4
2024-11-08	Moore, Mary Ann E	Officer	EVP, GC, Chief Admin Off & Sec	Direct	Sale	8,108	16.00	$129,728.00	135,810	4
2024-08-30	Swift, James D	Director,Officer	Chief Executive Officer	Direct	Sale	11,100	10.79	$119,769.00	170,001	4
2024-08-27	Linynsky, Laura A	Director	-	Direct	Sale	7,000	11.16	$78,120.00	30,805	4
2024-08-12	Richards, C Marc	Officer	EVP, Chief Financial Officer	Direct	Sale	17,438	10.08	$175,775.04	175,347	4
2023-12-14	Moore, Mary Ann E	Officer	EVP, General Counsel & Sec	Direct	Sale	970	9.62	$9,331.40	81,385	4
2023-12-14	Swift, James D	Director,Officer	Chief Executive Officer	Direct	Sale	5,764	9.58	$55,219.12	90,874	4
2023-06-14	Swift, James D	Director,Officer	Chief Executive Officer	Direct	Sale	13,193	14.14	$186,549.02	96,638	4
2023-05-25	Ordan, Mark S	Director	-	Direct	Sale	33,000	13.26	$437,580.00	147,923	4
2023-05-19	Weis, Shirley A	Director	-	Direct	Sale	1,007	13.63	$13,725.41	17,668	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

99.12%

Inst. Shares: 80,169,330

Shares Outstanding: 80,881,000

2025-12-31

95.26%

Inst. Shares: 80,097,076

Shares Outstanding: 84,080,000

2025-09-30

93.23%

Inst. Shares: 78,880,132

Shares Outstanding: 84,609,000

2025-06-30

92.80%

Inst. Shares: 78,691,457

Shares Outstanding: 84,797,000

2025-03-31

93.56%

Inst. Shares: 78,995,475

Shares Outstanding: 84,435,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	80,169,330	80,881,000	99.12%
2025-12-31	80,097,076	84,080,000	95.26%
2025-09-30	78,880,132	84,609,000	93.23%
2025-06-30	78,691,457	84,797,000	92.80%
2025-03-31	78,995,475	84,435,000	93.56%
2024-12-31	80,957,224	83,330,000	97.15%
2024-09-30	84,797,286	83,891,000	101.08%
2024-06-30	85,446,176	83,332,000	102.54%
2024-03-31	82,631,262	82,863,000	99.72%
2023-12-31	80,254,541	82,201,000	97.63%
2023-09-30	71,406,533	82,543,000	86.51%
2023-06-30	71,013,625	82,399,000	86.18%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Pediatrix Medical Group, Inc. (MD) — SEC Financial Statements & Analysis

Pediatrix Medical Group, Inc. (MD) is a services-hospitals company, incorporated in FL. Pediatrix Medical Group, Inc. trades on NYSE as: MD. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Pediatrix Medical Group, Inc. reported a 0.51% year-over-year revenue growth, a Gross Profit Margin of 102.07% (TTM), a Debt-to-Equity ratio of 1.42x, a Price-to-Sales (P/S) ratio of 1.03x (TTM), a Price-to-Book (P/B) ratio of 2.28x (TTM), at a market cap of $2.01B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 0.51%
Gross Profit Margin TTM: 102.07%
Debt To Equity: 1.42x
P/S TTM: 1.03x
P/B TTM: 2.28x
Market Cap: $2.01B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Pediatrix Medical Group, Inc. in?

Pediatrix Medical Group, Inc. (MD) operates in the Services-Hospitals industry.

What is MD's market cap?

Pediatrix Medical Group, Inc. (MD) has a market capitalization of $2.01B as of 2026-06-30.

What is MD's P/E ratio?

Pediatrix Medical Group, Inc. (MD)'s trailing twelve month P/E ratio is 11.51x as of 2026-06-30.

What exchange does MD trade on?

Pediatrix Medical Group, Inc. (MD) trades on the NYSE.

Where is Pediatrix Medical Group, Inc. incorporated?

Pediatrix Medical Group, Inc. is incorporated in FL.